Core Viewpoint - The investment landscape for 2026 is shaped by China's "14th Five-Year Plan," emphasizing high-quality development and strategic investment opportunities in various sectors [1][2][3]. Group 1: Investment Strategy and Macro Trends - The importance of a broad perspective in investment is highlighted, focusing on understanding macro trends and industry dynamics [2][19]. - The "14th Five-Year Plan" serves as a guiding framework for investment, emphasizing high-quality development and the need for innovative production capabilities [19][20]. - The ongoing global industrial transformation, driven by AI and technological advancements, presents significant investment opportunities in traditional and emerging industries [20][21]. Group 2: Sector-Specific Insights - The innovative pharmaceutical sector is poised for growth, with Chinese companies expected to see a doubling of license-out revenues to $121.6 billion by 2025 [21][22]. - The Hong Kong stock market is viewed positively, with major investment banks recognizing its potential as a hub for leading companies in technology and smart driving [23][24]. - The AI sector is seen as a transformative force, with applications in various industries expected to drive significant investment opportunities [24][25]. Group 3: Renewable Energy and New Materials - The renewable energy sector is anticipated to continue its upward trend, with lithium battery technology expected to see significant advancements [25][26]. - The chemical industry is also expected to recover, driven by long-term demand growth and supply-side reforms [25][26]. Group 4: Financial and Real Estate Sector - The financial and real estate sectors are showing signs of recovery, with a rebound in second-hand housing transactions indicating positive market sentiment [26][27]. - Investment opportunities in the insurance sector are expected to improve, alongside a focus on banks and brokerages with strong wealth management capabilities [26][27]. Group 5: Consumer Sector Dynamics - The consumer sector is undergoing a transformation, with new trends emerging in smart home products and lifestyle consumption, driven by younger generations [28][29]. - The aging population is creating new market opportunities in tourism, healthcare, and wellness sectors [28][29]. Group 6: Long-term Investment Philosophy - The emphasis on scientific long-termism in wealth management highlights the importance of strategic asset allocation for sustainable growth [29][30]. - The focus on retirement planning underscores the need for consistent investment strategies that adapt to changing market conditions [30][31].

Group 1 - The A-share market experienced a collective rebound on February 3, with over 4,800 stocks rising across the market [1] - Key sectors that performed well included photovoltaic equipment, CPO, commercial aerospace, engineering machinery, rare earth permanent magnets, cloud gaming, storage chips, cultivated diamonds, and epoxy propylene [1] - The CSI A500 index rose by 1.9%, the CSI 300 index increased by 1.2%, the ChiNext index gained 1.9%, and the STAR Market 50 index went up by 1.4%, while the Hang Seng China Enterprises Index fell by 0.3% [1] Group 2 - The ChiNext ETF tracks the ChiNext index, which consists of 100 stocks with high market capitalization and liquidity, with a significant proportion in strategic emerging industries, particularly in the power equipment, communication, and electronics sectors, which together account for nearly 60% [3] - The STAR 50 ETF tracks the STAR Market 50 index, composed of 50 stocks with high market capitalization and liquidity, prominently featuring "hard technology" leaders, with semiconductors making up over 65% and combined with medical devices and software development, accounting for 80% [5]

Group 1 - The core viewpoint indicates that the equity market and commodity market experienced a surge followed by a decline, with significant emotional amplification observed. The resource sector became the main focus of the market, leading to increased trading volume, but a subsequent profit-taking wave caused a sharp drop in precious and base metals, impacting the equity market as well [1][8][11] - The report highlights that the A-share market is experiencing increased volatility, with resource sectors like non-ferrous metals and gold taking over as the short-term market leaders. However, the market is cautioned against high-level risks due to the lack of performance support in low-performing sectors like liquor and real estate [2][12][11] - The report suggests a "barbell strategy" for asset allocation, recommending a focus on sectors that have undergone sufficient corrections, such as innovative pharmaceuticals and communications for the offensive side, while defensive opportunities may be found in dividend-paying sectors like banks [4][13] Group 2 - The bond market is showing signs of recovery, driven by expectations of increased liquidity and a shift of funds seeking safety from the equity market's volatility. This trend is expected to continue in the short term, although long-term challenges remain due to competition for capital from the commodity and equity markets [5][36] - The commodity market is under pressure after a period of rapid growth, with significant corrections observed in precious metals and other commodities. The report warns of potential volatility in the short term but notes that long-term demand for gold and industrial metals remains strong due to technological advancements [6][45][44] - The report emphasizes the importance of monitoring the dual innovation narrative in the equity market, as it is expected to drive future growth amid ongoing liquidity support and a global easing cycle [12][11][13]

Core Viewpoint - The A-share market is experiencing significant volatility, but the medium-term upward trend remains intact according to Shangyin Fund, supported by three main factors [1]. Group 1: Market Trends - The global backdrop of "asset scarcity" continues, coupled with frequent geopolitical conflicts, which sustains the long-term trend of "patient capital" flowing into the stock market [1]. - Domestic policies aimed at reducing "involution" are being implemented, leading to improved expectations for corporate profitability, which provides a stabilizing effect on the capital market [1]. - The recent rapid adjustments in market sectors are primarily reactions to short-term market sentiment and trading dynamics, rather than fundamental changes, thus not undermining the medium to long-term upward trend [1]. Group 2: Investment Opportunities - Investment opportunities can be categorized into three areas: 1. AI-related industries, where domestic policies are supporting the AI industry chain, and capital expenditure in global computing power is expected to expand, with a focus on domestic computing chains and AI in gaming [2]. 2. The enhancement of Chinese brand competitiveness, transitioning from "cheap goods" to "high-quality and cost-effective" products, with notable advancements in sectors like innovative pharmaceuticals, power equipment, and construction machinery [2]. 3. Resource sectors, particularly copper and minor metals, which possess genuine scarcity and anti-inflation properties, forming stable supply alliances and showcasing significant long-term investment value [2]. - The adjustment in the non-ferrous metals sector, which has seen significant prior gains and high congestion, is viewed as a necessary period for digestion rather than a fundamental downturn, with potential for attractive buying opportunities post-adjustment [2].

Market Performance - The A-share market showed weakness today, with the Shanghai Composite Index falling by 2.5% [1][5] - Major indices experienced declines, including the CSI 300 down 2.1%, the STAR 50 down 3.9%, and the ChiNext Index down 2.5% [1][5] - The trading volume today was 2.6 trillion yuan, a decrease of approximately 0.26 trillion yuan compared to the previous trading day [1][5] External Factors - The adjustment in the A-share market is primarily attributed to increased external uncertainties, including the nomination of Kevin Walsh as the next Federal Reserve Chairman, which has affected expectations for U.S. monetary policy [2][6] - Global commodity prices have sharply declined, impacting market sentiment and risk appetite, with significant drops in gold and other commodities [2][6] Investment Strategy - The current market volatility presents opportunities for bottom-fishing, as the underlying positive factors such as ample liquidity and improving performance remain unchanged [3][7] - The market is expected to continue supporting Chinese assets in 2026, driven by the restructuring of international order and domestic industrial innovation trends [3][7] Sector Focus - Suggested areas for investment include: 1. Growth sectors such as AI technology, cloud computing, and innovative pharmaceuticals, which are entering a growth cycle [4][8] 2. Export-oriented sectors, particularly in home appliances, engineering machinery, and gaming, which are seen as stable growth opportunities [4][8] 3. Cyclical sectors like chemicals and renewable energy, which may benefit from improving supply-demand dynamics [4][8] 4. High-dividend stocks, which are attractive for long-term investors seeking stable cash flow [4][8]

建议逢低布局。本次波动与美联储主席提名引发的美宽松预期变化有关，但更主要的可能是此前大宗商 品价格过快上行，交易拥挤度较高，一旦预期变化将引发头寸集中抛售。并且该行认为凯文·沃什的决 策可能受到较多制约，美联储难以像市场担忧彻底转为鹰派，市场短期可能已经提前计入较多悲观预 期。A股当前资金面充裕、业绩改善、产业趋势催化等积极因素并未发生改变，该行认为短期波动已开 始提供逢低布局机会。中期而言，该行在此前研报中指出，国际秩序重构与我国产业创新趋势共振是推 动本轮市场上涨、中国资产重估的核心驱动力；全球货币秩序重构带来的格局转换和资金流动的力量， 或远大于一时、一国和一市场的基本面力量。该行认为，这两大条件未发生改变，2026年将继续支持中 国资产表现。 A股今日表现偏弱，上证指数下跌2.5%。2026年初A股市场在乐观预期、产业事件性催化、流动性相对 充裕等因素影响下延续上行趋势，但换手率过高、情绪偏热后，市场自1月13日震荡调整。今日A股市 场主要指数普跌，上证指数跌2.5%，沪深300跌2.1%，偏成长风格的科创50和创业板指分别跌3.9%、 2.5%，中证红利跌3.1%。成交层面，今日成交额2.6万亿元， ...

Market Overview - The A-share market experienced a significant decline, with the Shanghai Composite Index dropping 2.48% to 4015.75 points and the Shenzhen Component Index falling 2.69% to 13824.35 points, as trading volume reached 2.6 trillion yuan, slightly lower than the previous day [1] - The market sentiment was negatively impacted by the nomination of Kevin Warsh as the next Federal Reserve Chairman, raising concerns about prolonged high interest rates and a notable drop in risk appetite [1] Pharmaceutical and Biotech Sector - The pharmaceutical and biotech sector demonstrated strong capital attraction, with the Guotai Innovation Drug ETF (589720) seeing a net inflow of 667 million yuan over ten consecutive trading days [3][4] - Key mergers and acquisitions, such as China Biopharmaceutical's acquisition of Hejia Biotech for 1.2 billion yuan and Rongchang Biopharmaceutical's exclusive licensing agreement with AbbVie worth up to 650 million USD, have boosted market confidence and highlighted the global competitiveness of Chinese pharmaceutical companies [3][4] - The investment logic in the pharmaceutical sector is supported by "innovation realization" and "valuation recovery," as domestic innovative drugs enter a commercialization and internationalization phase [3][4] Solar Energy Sector - The solar energy sector saw a strong performance, with the solar industry index rising over 2% before retreating, driven by Tesla CEO Elon Musk's proposal for a "space solar" project [5][6] - The sector is transitioning from a "post-decline rebound" to a deeper "supply-demand pattern reshaping," with significant potential for Chinese solar companies due to their advantages in equipment and core material supply [5][6] - The solar industry has faced intense price competition, leading to significant losses for major players, but recent policies aimed at reducing competition and clearing out outdated capacity are expected to enhance market concentration and improve the profitability of leading firms [5][6] Electric Grid Sector - The electric grid sector is experiencing robust domestic demand, with transformer factories in regions like Guangdong and Jiangsu operating at full capacity, and significant investments expected from the State Grid Corporation [7][8] - Major electric grid equipment companies reported impressive earnings, with projected revenues of 21.205 billion yuan, a 37.18% increase year-on-year, and net profits of 3.163 billion yuan, up 54.35% from the previous year [7][8] - The global energy transition is driving demand for electric grid construction, particularly in underdeveloped regions, presenting substantial growth opportunities for domestic electric grid companies [7][8] Precious Metals Sector - The precious metals sector, particularly gold, is undergoing significant volatility, with COMEX gold prices dropping below 4500 [9][10] - Concerns over monetary policy tightening following Warsh's nomination have led to market sell-offs, exacerbated by high leverage and profit-taking after previous price surges [9][10] - Despite short-term adjustments, long-term support for gold prices remains due to expectations of Federal Reserve rate cuts and ongoing geopolitical tensions [9][10]

恒瑞医药董事长 孙飘扬 作为国内创新药龙头企业，恒瑞医药面对医药行业技术创新与同质化竞争并存的复杂局面，2025年在创新研发与国际拓展方面取得关键 突破，全年获批7款1类创新药，创新药上市总数达24款，并成功实现"A+H"双资本平台布局。2026年，恒瑞医药董事长孙飘扬表 示："要持续加大研发投入，聚焦肿瘤、自免、代谢疾病等重点领域，进一步构筑'新、特、快'产品核心优势，深化ADC、双抗等技术平 台建设，催生更多差异化创新成果，解决未获满足的临床需求。"同时通过强化全球临床布局与商业化能力，系统推动中国创新药在国 际市场的价值实现，以可持续的创新生态助力健康中国建设。 背景介绍： 当2025年的日历翻至末页，生物医药产业正站在一个特殊的历史节点——这既是"十四五"的收官沉淀之年，更是"十五五"宏伟蓝图的启 航之时。这一年，技术狂飙与商业理性的碰撞、全球化布局与本土化深耕的平衡、"创新驱动"向"价值驱动"的范式转型，共同勾勒出 2025年的行业主线。2026年，产业如何跨越技术周期与资本周期的双重考验，在"健康中国"战略与全球创新格局双轨并行中，探寻可持 续增长路径？思享启发思想，"生物医药大健康2026思享汇 ...

系统性升级。 《投资者网》蔡俊 1月，港股再掀创新药IPO盛宴。 相较2018年至2021年的热潮，本次盛宴在底层逻辑上有了深刻改变。一方面，资本更趋理性，不再以故事驱动估值判定，而是从确定性的结果中给出价值。 另一方面，本轮参与企业的成分更为多元，既有Biotech大军，也有两地上市及分拆上市的新形态。 说到底，新一轮的盛宴以更升级的方式完成自我进化。这轮在创新药行情后紧接而来的IPO热潮能持续多久，值得观察。 盛宴再度开启 截至1月，共有7家创新药企向港交所递交招股书，包括博锐生物、先声再明、赜灵生物、亦诺微、勤浩医药、普祺医药、迪哲医药等。 期间，精锋医疗和瑞博生物成功在港交所挂牌，分别对应手术机器人、小核酸药物等赛道，合计募资超40亿元。 之所以选择港股，在于大多数企业仍亏损，由此适配港交所的18A/18C规则，即未盈利科技企业至少1个核心产品进入临床阶段，就可走快速通道冲击IPO。 而且，这些企业的募资需求相当明确，用途也高度一致：核心用于管线临床推进、商业化产能建设、技术平台升级等。其中，迪哲医药已上市科创板，因此 本次意在冲击"A+H"两地上市。 截至目前，迪哲医药的A股市值超250亿元。202 ...

Core Insights - In January, Chengdu recorded 28 investment events related to technology innovation and entrepreneurship, with data sourced from public disclosures and institutional information [2] Group 1: Investment Events - Chengdu Yongzhi Technology completed an undisclosed equity financing round, focusing on intelligent computing infrastructure technology [5] - Chengdu Dianke Guoxin Technology completed an undisclosed equity financing round, specializing in microwave and millimeter-wave integrated circuits [6] - Chengdu Tiancheng Electric Technology completed an undisclosed equity financing round, focusing on miniaturized and low-cost millimeter-wave micro-systems [7] - Chengdu Xingtuo Microelectronics completed a C round financing of several hundred million RMB, aimed at high-performance interconnect chip development [9] - Chengdu Huayuan Technology completed a C1 round financing, becoming a notable player in the AI+AR smart glasses sector with nearly 500 million RMB raised over the past year [12] - Chengdu Weirui Network Technology completed approximately 100 million RMB in A round financing, focusing on high-end CT tube development [23] Group 2: Industry Focus - The electronic information sector was the most active, with 10 investment events, while the health sector followed closely with 9 events, indicating a strong interest in these industries [4] - 35% of the financed projects were related to the electronic information industry ecosystem, while 32% were linked to the health industry ecosystem [4] Group 3: Company Developments - Chengdu NiuRuiTe Medical Technology initiated IPO counseling, focusing on medical isotopes and drug innovation [30] - Chengdu Xingtuo Microelectronics completed IPO counseling registration, specializing in interconnect chip solutions [31] - Chengdu Olin Biotechnology submitted listing materials to the Hong Kong Stock Exchange, focusing on human vaccine development [32] - Chengdu Super Pure Application Materials' IPO application was accepted, aiming to raise 1.124 billion RMB for semiconductor equipment [33] - Chengdu Xinyi Technology is set to be acquired by Blue Arrow Electronics, with a valuation of up to 675 million RMB [34]